Clemens Fischer
Chairman at PHARMASGP HOLDING SE
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Madlena Hohlefelder | F | 43 |
Futrue GmbH
 Futrue GmbH Pharmaceuticals: MajorHealth Technology Futrue GmbH is an international healthcare incubator with over 20 companies and more than 70 approved pharmaceutical products. Futrue is based in Graefeling, DE and was founded by Madlena Hohlefelder and Clemens Fischer. The German company focuses on smart bacteria and operates in the healthcare industry. Clemens Fischer has been the CEO since incorporation.
PharmaSGP GmbH
 PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services PharmaSGP GmbH focuses on the development and distribution of chemical-free drugs on pain therapy. It brands include RUBAXX® for rheumatic pain, RESTAXIL® for neuralgic pain (nerve pain) and DESEO® and NERADIN® for against sexual weakness & vertigo symptoms. The company was founded by Madlena Hohlefelder and Clemens Fischer in 2009 and is headquartered in Gräfelfing, Germany. | 17 years |
| Axel Rebien | M | 52 |
Futrue GmbH
Futrue GmbH Pharmaceuticals: MajorHealth Technology Futrue GmbH is an international healthcare incubator with over 20 companies and more than 70 approved pharmaceutical products. Futrue is based in Graefeling, DE and was founded by Madlena Hohlefelder and Clemens Fischer. The German company focuses on smart bacteria and operates in the healthcare industry. Clemens Fischer has been the CEO since incorporation.
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services PharmaSGP GmbH focuses on the development and distribution of chemical-free drugs on pain therapy. It brands include RUBAXX® for rheumatic pain, RESTAXIL® for neuralgic pain (nerve pain) and DESEO® and NERADIN® for against sexual weakness & vertigo symptoms. The company was founded by Madlena Hohlefelder and Clemens Fischer in 2009 and is headquartered in Gräfelfing, Germany. | 6 years |
| Natalie Weigand | F | 43 |
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services PharmaSGP GmbH focuses on the development and distribution of chemical-free drugs on pain therapy. It brands include RUBAXX® for rheumatic pain, RESTAXIL® for neuralgic pain (nerve pain) and DESEO® and NERADIN® for against sexual weakness & vertigo symptoms. The company was founded by Madlena Hohlefelder and Clemens Fischer in 2009 and is headquartered in Gräfelfing, Germany. | 9 years |
| Michael Rudolf | M | 50 |
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services PharmaSGP GmbH focuses on the development and distribution of chemical-free drugs on pain therapy. It brands include RUBAXX® for rheumatic pain, RESTAXIL® for neuralgic pain (nerve pain) and DESEO® and NERADIN® for against sexual weakness & vertigo symptoms. The company was founded by Madlena Hohlefelder and Clemens Fischer in 2009 and is headquartered in Gräfelfing, Germany.
Futrue GmbH
Futrue GmbH Pharmaceuticals: MajorHealth Technology Futrue GmbH is an international healthcare incubator with over 20 companies and more than 70 approved pharmaceutical products. Futrue is based in Graefeling, DE and was founded by Madlena Hohlefelder and Clemens Fischer. The German company focuses on smart bacteria and operates in the healthcare industry. Clemens Fischer has been the CEO since incorporation. | 8 years |
| Doris Schmitt-Landsiedel | M | 71 |
Technische Universität München
| 28 years |
| Rudolf Faltermeier | M | 76 |
Technische Universität München
| 23 years |
| David Scharfstein | M | 63 |
Harvard Business School
| 21 years |
| Thomas Friedrich Neuhann | M | 78 |
Technische Universität München
| 27 years |
| Lara Mögenburg | F | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ralph Lassig | M | - |
Technische Universität München
| 12 years |
| Aaron Michel | M | - |
Harvard Business School
| 3 years |
| Alex Sloane | M | - |
Harvard Business School
| 10 years |
| Andreas Unseld | M | - |
Technische Universität München
| 7 years |
| Alex Wonhas | M | - |
Technische Universität München
| 5 years |
| Andreas Schaller | M | - |
Technische Universität München
| 6 years |
| Rainer Maerkle | M | 49 |
Technische Universität München
| 6 years |
| Marion Weissenberger-Eibl | M | 57 |
Technische Universität München
| 6 years |
| Florian Dillinger | M | - |
Technische Universität München
| 4 years |
| Marc Al-Hames | M | 46 |
Technische Universität München
| 8 years |
| Christian Schubert | M | - |
Technische Universität München
| 5 years |
| Moritz Friedrich Arne Hilf | M | - |
Technische Universität München
| 6 years |
| Jonathan T. Pastor | M | - |
Harvard Business School
| 2 years |
| Adrian Mucalov | M | - |
Harvard Business School
| 3 years |
| Emily johnson lambert | F | - |
Harvard Business School
| 2 years |
| Marco Giberti | M | - |
Harvard Business School
| 3 years |
| Edis Jamyn | M | - |
Harvard Business School
| 2 years |
| Francois Dufour | M | - |
Harvard Business School
| 2 years |
| Nidhi Chadda | F | - |
Harvard Business School
| 2 years |
| Joel M. Podolny | M | - |
Harvard Business School
| 3 years |
| Allison Checchi | F | - |
Harvard Business School
| 2 years |
| Adam Said | M | 40 |
Harvard Business School
| 2 years |
| Rubens Mário Marques de Freitas | M | 46 |
Harvard Business School
| 2 years |
| Yon Sog Choi | M | - |
Harvard Business School
| 2 years |
| Lea Bajc | F | - |
Harvard Business School
| 2 years |
| Juan Enriquez | M | 64 |
Harvard Business School
| 2 years |
| Jose Valentin Pantangco | M | 52 |
Harvard Business School
| 2 years |
| Morven Groves | F | - |
Harvard Business School
| 2 years |
| Justin Keppy | M | 51 |
Harvard Business School
| 2 years |
| Ken Kajii | M | - |
Harvard Business School
| 2 years |
| Puja Jaspal | F | - |
Harvard Business School
| 2 years |
| Alex Wolff | M | - |
Harvard Business School
| 2 years |
| Aliceson Robinson | M | - |
Harvard Business School
| 2 years |
| Hector Gil | M | - |
Harvard Business School
| 2 years |
| Alexis DePree | F | 45 |
Harvard Business School
| 2 years |
| Stephanie Holden | F | - |
Harvard Business School
| 2 years |
| Vanessa Ann Bartram | F | - |
Harvard Business School
| 2 years |
| Showbhik Kalra | M | - |
Harvard Business School
| 2 years |
| Leslie Feinzaig | F | - |
Harvard Business School
| 2 years |
| Sherrese Soares | F | 47 |
Harvard Business School
| 2 years |
| Marc Herdegen | M | - |
Harvard Business School
| 2 years |
| Bijan Salehizadeh | M | - |
Harvard Business School
| 2 years |
| Julia Feldman | F | - |
Harvard Business School
| 2 years |
| Mina Pacheco Nazemi | F | - |
Harvard Business School
| 2 years |
| Ah Kee Low | M | 44 |
Harvard Business School
| 2 years |
| Ingo Rudolf Ederer | M | 56 |
Technische Universität München
| 3 years |
| David Salanic | M | - |
Harvard Business School
| 2 years |
| Bobby J. Sheth | M | 45 |
Harvard Business School
| 2 years |
| Ashutosh Agrawal | M | - |
Harvard Business School
| 2 years |
| Jeff Swenson | M | 48 |
Harvard Business School
| 2 years |
| Scott Alan Cullerton | M | - |
Harvard Business School
| 2 years |
| Danielle Hootnick | F | - |
Harvard Business School
| 2 years |
| Benjamin A. Farkas | M | - |
Harvard Business School
| 3 years |
| Patrick McGinnis | M | - |
Harvard Business School
| 2 years |
| Fazeela A. Rashid | F | - |
Harvard Business School
| 2 years |
| Jill Catherine Raker | F | - |
Harvard Business School
| 2 years |
| Eliot E. Kerlin | M | 50 |
Harvard Business School
| 2 years |
| David Matthew Friedman | M | - |
Harvard Business School
| 2 years |
| Edward Sobol | M | - |
Harvard Business School
| 2 years |
| David Bordeau | M | - |
Harvard Business School
| 2 years |
| Barkley J. Stuart | M | - |
Harvard Business School
| 2 years |
| Craig Stern | M | - |
Harvard Business School
| 2 years |
| Sharmil S. Modi | M | - |
Harvard Business School
| 2 years |
| Jason Goins | M | - |
Harvard Business School
| 2 years |
| Douglas Simmons | M | - |
Harvard Business School
| 2 years |
| Brian Wayne Lemasters | M | - |
Harvard Business School
| 2 years |
| Marc André Novakoff | M | 49 |
Harvard Business School
| 2 years |
| Jeremy A. Lynch | M | - |
Harvard Business School
| 2 years |
| Aaron A. Bendikson | M | 50 |
Harvard Business School
| 2 years |
| Christopher M. Busby | M | - |
Harvard Business School
| 2 years |
| Min Zhang | F | 50 |
Harvard Business School
| 2 years |
| John Doran | M | 45 |
Harvard Business School
| 2 years |
| Samuel Clemens | M | - |
Harvard Business School
| 2 years |
| Adam Dean Checchi | M | - |
Harvard Business School
| 2 years |
| Özlem Tekay | F | - |
Harvard Business School
| 4 years |
| Alex Popa | M | - |
Harvard Business School
| 2 years |
| Dong Hao Yang | M | 52 |
Harvard Business School
| 2 years |
| So-Youn Song | M | - |
Harvard Business School
| 2 years |
| Joseph Kauffman | M | 46 |
Harvard Business School
| 2 years |
| Laura Grattan | F | 42 |
Harvard Business School
| 2 years |
| Ade Patton | M | 45 |
Harvard Business School
| 2 years |
| Chris Markgraf | M | - |
Harvard Business School
| 2 years |
| Srdjan Tanjga | M | - |
Harvard Business School
| 2 years |
| Lee Rand | M | - |
Harvard Business School
| 2 years |
| Nico Iacuzzi | M | - |
Harvard Business School
| 2 years |
| Tim Liu | M | - |
Harvard Business School
| 2 years |
| Alex Kinnier | M | 48 |
Harvard Business School
| 2 years |
| Alex Alvarez | M | - |
Harvard Business School
| 2 years |
| Sameer Dholakia | M | 50 |
Harvard Business School
| 2 years |
| Lily Surya | F | - |
Harvard Business School
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 80 | 80.81% |
| Germany | 19 | 19.19% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Clemens Fischer
- Personal Network
